Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Rubius Therapeutics to Announce Second Quarter 2021 Financial Results | ||
By: GlobeNewswire - 22 Jul 2021 | Back to overview list |
|
CAMBRIDGE, Mass., July 22, 2021 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq: RUBY), a clinical-stage biopharmaceutical company that is genetically engineering red blood cells to create an entirely new class of cellular medicines called Red Cell Therapeutics™ for the treatment of cancer and autoimmune diseases, today announced plans to report second quarter financial results on Monday, August 9, 2021, before market open. The company will not be hosting a teleconference in conjunction with its financial results press release. About Rubius Therapeutics Contacts: Dan Budwick |
||
|
||
Copyright 2021 GlobeNewswire | Back to overview list |